RADNOR, Pa., Nov. 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”) The lead p ...

Core Viewpoint - Acadia Healthcare Company, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims of misleading practices and abuse within its facilities during the specified class period [1][4]. Group 1: Allegations and Impact - The lawsuit alleges that Acadia's business model involved holding patients against their will without medical necessity, leading to abuse within its facilities [4]. - A New York Times article published on September 1, 2024, highlighted these practices, resulting in a stock price drop of over 4% [5]. - Following a disclosure on September 27, 2024, regarding a grand jury subpoena and requests for information from the U.S. Attorney's Office, Acadia's stock price fell more than 16% [6]. Group 2: Legal Process and Representation - Investors who purchased Acadia's publicly traded securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [7]. - The lead plaintiff will have the authority to select a law firm for litigation, but participation as lead plaintiff does not affect the ability to share in any potential recovery [7]. Group 3: Company Background - Acadia Healthcare provides behavioral healthcare services and has been implicated in serious allegations regarding its treatment of patients [3]. - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is recognized for its significant recoveries in securities fraud cases, having secured $6.6 billion for investors in related class action cases [8].

NEW YORK, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

RADNOR, Pa., Nov. 23, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period")  The lead plaintiff deadline is December 16, 2024.CONTACT KESSLER TOPAZ MELTZER & CHECK ...

NEW YORK, Nov. 22, 2024 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the "Class Period"), of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.So what: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without paymen ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Acadia Healthcare between February 28, 2020 and October 18, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YOR ...

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) publicly traded securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), have until Monday, December 16, 2024 to seek appointment as lead plaintiff of the Acadia Healthcare class action lawsuit. Captioned Kachrodia v. Acadia Healthcare Company, Inc., No. 24-cv-01238 (M.D. Tenn.), the Acadia Healt ...

Shares of Acadia Healthcare Company, Inc. (ACHC) have dropped 24.3% over the past month to close at $39.10 on Wednesday. The steep decline has pushed the stock’s price closer to the lower end of its 52-week range of $36.50-$87.77. It underperformed its peers like Tenet Healthcare Corporation (THC) and Universal Health Services, Inc. (UHS) , the overall industry, and the S&P 500 Index.The company’s current share price might seem like an excellent opportunity to build a position in a renowned behavioral healt ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $100,000 in Acadia Healthcare between February 28, 2020 and September 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, ...